Product information
From Health Canada
Current status:
Dormant
Current status date:
2017-07-24
Original market date: See footnote 1
1995-12-31
Product name:
33.3% DEXTROSE INJECTION, USP
DIN:
02014831 Electronic product monograph is not available
Company:
BAXTER CORPORATION
7125 Mississauga Road
Mississauga
Ontario
Canada
L5N 0C2
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
40:20.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
B05BA03 CARBOHYDRATES
Active ingredient group (AIG) number:See footnote5
0102181005
Active ingredient(s) | Strength |
---|---|
DEXTROSE | 33.3 G / 100 ML |